ribavirin has been researched along with Hepatolenticular Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida-Santos, M; Barroso, E; Carmo, J; Curran, M; Marques, S; Mateus, É; Morbey, A; Veloso, J | 1 |
| Maier, KP | 1 |
1 review(s) available for ribavirin and Hepatolenticular Degeneration
| Article | Year |
|---|---|
[Drug therapy in chronic liver disease].
Topics: Adenine; Administration, Oral; Anti-HIV Agents; Antiviral Agents; Azathioprine; Cholangitis, Sclerosing; Chronic Disease; Drug Therapy, Combination; Fatty Liver; Hemochromatosis; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Autoimmune; Hepatolenticular Degeneration; Humans; Immunosuppression Therapy; Interferons; Lamivudine; Liver Cirrhosis, Biliary; Liver Diseases; Organophosphonates; Prednisolone; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Ribavirin; Time Factors | 2005 |
1 other study(ies) available for ribavirin and Hepatolenticular Degeneration
| Article | Year |
|---|---|
Ribavirin for Chronic Hepatitis E in Liver-Transplant Setting: A Safe and Highly Effective Therapy.
Topics: Adult; Amyloid Neuropathies, Familial; Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis E; Hepatitis, Chronic; Hepatolenticular Degeneration; Humans; Interferon-alpha; Liver Transplantation; Ribavirin; Treatment Outcome | 2016 |